WallStSmart

Nano Labs Ltd (NA)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 859% more annual revenue ($258.90M vs $27.01M). NA leads profitability with a 502.0% profit margin vs -15.5%. NA earns a higher WallStSmart Score of 56/100 (C).

NA

Buy

56

out of 100

Grade: C

Growth: 4.7Profit: 6.0Value: 8.3Quality: 5.0

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NAUndervalued (+50.8%)

Margin of Safety

+50.8%

Fair Value

$6.14

Current Price

$1.60

$4.54 discount

UndervaluedFair: $6.14Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NA5 strengths · Avg: 9.4/10
P/E RatioValuation
1.6x10/10

Attractively priced relative to earnings

Price/BookValuation
0.3x10/10

Reasonable price relative to book value

Profit MarginProfitability
502.0%10/10

Keeps 502 of every $100 in revenue as profit

Return on EquityProfitability
25.9%9/10

Every $100 of equity generates 26 in profit

Revenue GrowthGrowth
18.1%8/10

18.1% revenue growth

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

NA4 concerns · Avg: 2.5/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$37.26M3/10

Smaller company, higher risk/reward

Free Cash FlowQuality
$-108.32M2/10

Negative free cash flow — burning cash

Operating MarginProfitability
-195.0%1/10

Operating margin of -195.0%

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : NA

The strongest argument for NA centers on P/E Ratio, Price/Book, Profit Margin. Profitability is solid with margins at 502.0% and operating margin at -195.0%. Revenue growth of 18.1% demonstrates continued momentum.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : NA

The primary concerns for NA are EPS Growth, Market Cap, Free Cash Flow.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

NA profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

NA carries more volatility with a beta of 5.31 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor SEMICONDUCTORS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NA scores higher overall (56/100 vs 41/100), backed by strong 502.0% margins and 18.1% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Nano Labs Ltd

TECHNOLOGY · SEMICONDUCTORS · USA

Nano Labs Ltd is a factory-free integrated circuit (IC) design company and product solution provider in the People's Republic of China. The company is headquartered in Hangzhou, the People's Republic of China.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?